Yes. You can have fatty liver disease — and even significant fibrosis — with completely normal liver enzymes. ALT and AST measure liver-cell injury, not fat and not scarring, and they're often normal in MASLD. Normal enzymes are reassuring but they do not rule out at-risk liver disease. Fibrosis risk is judged with FIB-4 and, if needed, elastography.
Section accent: --clay (MASLD pillar, scoped in-family). Flagship acquisition page for the "normal enzymes" question.
The short answer: yes, you can
This is one of the most consequential misunderstandings in metabolic medicine, so we'll state it plainly: normal liver enzymes do not rule out fatty liver disease, and they do not rule out significant fibrosis.
Many people are told their "liver tests are normal" and reasonably conclude their liver is fine. But ALT and AST are not fat tests and not fibrosis tests. A substantial proportion of people with MASLD — including some with advanced fibrosis — have normal ALT and AST. Fibrosis can be, in effect, silent on routine bloodwork. That single fact is why the diagnostic pathway doesn't stop at the liver panel. → What Is MASLD?
What ALT and AST actually measure
ALT (alanine aminotransferase) and AST (aspartate aminotransferase) are enzymes that live inside liver cells. When liver cells are injured and leak, blood levels rise. So the liver panel is a rough marker of ongoing hepatocyte injury — not a measure of:
- liver fat (steatosis), or
- liver scarring (fibrosis).
Enzymes can be normal when: - there's plenty of fat but limited active injury, - injury has "burned out" as disease advances (paradoxically, enzymes can fall as fibrosis progresses toward cirrhosis), - the reference range itself is generous — many labs' "normal" upper limits are higher than what some experts consider truly healthy, so a "normal" value can still be relatively elevated.
They can also be elevated for reasons unrelated to fibrosis (medications, alcohol, muscle injury for AST, other liver conditions). In short, enzymes are context, not a fibrosis verdict. → Weight-Loss Lab Library: ALT/AST
Why this trips people up — the fat ≠ fibrosis mismatch
The confusion comes from collapsing three separate things into one word, "liver." But:
- Fat (steatosis) — detected by imaging (ultrasound, CT, MRI, MRI-PDFF, CAP).
- Injury — reflected, imperfectly, by ALT/AST.
- Scarring (fibrosis) — the thing that actually predicts outcomes — assessed by FIB-4, elastography, or biopsy.
A person can sit anywhere across these independently: fatty liver with normal enzymes and no scarring; fatty liver with normal enzymes but real fibrosis; normal-looking imaging with abnormal enzymes from another cause. The amount of fat, the level of the enzymes, and the degree of scarring are three different measurements — and the one that matters most for prognosis (fibrosis) is precisely the one the liver panel doesn't measure. → FibroScan & Elastography
So what does find the risk?
If enzymes can't exclude fibrosis, what can? The noninvasive pathway is built for exactly this problem:
- FIB-4 — a score from age, AST, ALT and platelets. It weights age and platelet count, not just enzymes, so it can flag risk that a "normal" enzyme value would miss. A low FIB-4 is a genuinely reassuring rule-out; an indeterminate or high one prompts the next test. → FIB-4 Explained
- Elastography (FibroScan/VCTE or MRE) — measures liver stiffness (kPa) as a fibrosis surrogate; the same FibroScan reports CAP for fat. → FibroScan & Elastography
- Biopsy — the reference standard, reserved for selected uncertain cases. → Liver Biopsy: When It's Needed
This is why the answer to "my enzymes are normal, am I fine?" is: your enzymes are one data point; your fibrosis risk needs its own assessment. → The W8Experts Diagnostic Approach
When normal enzymes SHOULD still trigger a fibrosis check
Normal enzymes are not a reason to skip fibrosis-risk assessment if you carry metabolic risk. Consider a FIB-4 (regardless of enzyme values) if you have:
- Type 2 diabetes or prediabetes — a majority of people with diabetes have MASLD, and diabetes drives progression.
- Obesity or central adiposity / metabolic syndrome.
- An incidentally discovered fatty liver on any scan.
- Other metabolic risk (high triglycerides, low HDL, hypertension), or a family history of cirrhosis.
In these groups, "normal liver tests" is not the reassurance it sounds like. → Who Should Be Evaluated?
The balanced message
None of this means normal enzymes are meaningless or that everyone should panic. For a low-risk person with no metabolic risk factors and normal imaging, normal enzymes are genuinely reassuring, and no fatty-liver workup is needed. The point is narrower and important: in people with metabolic risk, normal enzymes do not exclude at-risk liver disease — so the decision to assess fibrosis should be driven by your risk profile and FIB-4, not by the liver panel alone.
SIGNATURE — "What the evidence says: Normal enzymes"
- What we know: ALT/AST measure hepatocyte injury, not fat or fibrosis; MASLD — including advanced fibrosis — frequently occurs with normal enzymes; enzymes can even fall as disease advances.
- What we think: Relying on the liver panel to exclude fibrosis is a common and consequential error; risk-based FIB-4 assessment catches disease enzymes miss.
- What we don't know: The ideal enzyme "normal" thresholds, and how best to screen every subgroup with normal enzymes.
- What patients should do: If you have metabolic risk, don't accept "your liver tests are normal" as the end of the story — ask about a fibrosis-risk assessment (FIB-4, then elastography if needed). → FIB-4 Explained
Questions patients ask
Can you have fatty liver with normal liver enzymes?
Yes — commonly. ALT and AST measure liver-cell injury, not fat, and are often normal in MASLD. Normal enzymes don't rule out fatty liver. Grade A 🟢
Can I have liver fibrosis if my enzymes are normal?
Yes. Significant fibrosis — even advanced fibrosis — can exist with normal ALT and AST. Enzymes are not a fibrosis test, which is why FIB-4 and elastography are used. Grade A 🟢 → FIB-4 Explained
What do ALT and AST actually measure?
They're enzymes that leak from injured liver cells, so they roughly mark ongoing liver-cell injury — not liver fat and not scarring. Grade A 🟢
Why can enzymes be normal if my liver is scarred?
Because injury and scarring are different processes. Active injury can be limited, or can even "burn out" as fibrosis advances, so enzymes may be normal or fall while scarring persists. Grade B 🟡
If enzymes don't show fibrosis, what does?
FIB-4 (which weights age and platelets, not just enzymes), then elastography such as FibroScan or MRE, and biopsy for selected cases. Grade A 🟢 → FibroScan & Elastography
My doctor said my liver tests are normal — am I in the clear?
If you have no metabolic risk factors, that's reassuring. If you have diabetes, obesity or metabolic syndrome, normal enzymes don't exclude at-risk liver disease, and a FIB-4 is still worthwhile. Grade A 🟢 → Who Should Be Evaluated?
Why is my "normal" range still a bit high?
Many labs set generous upper limits for ALT/AST, so a value inside "normal" can still be relatively elevated. That's another reason not to lean on the enzyme number alone. Grade B 🟡
Can liver enzymes be normal in advanced disease or cirrhosis?
Yes — enzymes can be normal or even low in advanced fibrosis and cirrhosis, so a normal panel is not evidence against advanced disease. Grade B 🟡
Should I get a FIB-4 even if my enzymes are normal?
If you have metabolic risk factors, yes. FIB-4 can flag fibrosis risk that normal enzymes miss, and a low score is a genuine rule-out. Grade A 🟢 → FIB-4 Explained
Do normal enzymes mean I don't need a FibroScan?
Not necessarily. The decision to do elastography follows your FIB-4 and risk profile, not your enzyme values — normal enzymes alone don't settle it. Grade A 🟢
If everything's normal and I have no risk factors, do I need any liver testing?
Generally no. For a low-risk person with normal imaging and no metabolic risk, normal enzymes are reassuring and no fatty-liver workup is needed. Grade B 🟡
KEEP READING
- FIB-4 Explained — the score that finds fibrosis risk enzymes miss.
- FibroScan & Elastography — measuring stiffness (fibrosis) versus fat.
- The W8Experts Diagnostic Approach — why the workup doesn't stop at the liver panel.
- Who Should Be Evaluated? — the metabolic risk profile that overrides "normal enzymes."
- Liver Biopsy: When It's Needed — the reference standard, used selectively.
Written by Darius A. Schneider, MD, PhD · Board-Certified Endocrinologist (ECNU) · Last updated: 2026-08-10 · References: AASLD Practice Guidance on MASLD (2023); EASL–EASD–EASO clinical practice guidance; literature on normal-ALT MASLD and fibrosis. Educational; not a diagnosis.
